(Q74433078)

English

Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe

scientific article published on 12 April 2002

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

title

Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

W Wolfgang Fleischhacker

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

Tom Burns

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

European Group For Research In Schizophrenia

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

publication date

12 April 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

volume

162

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

page(s)

82-84

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12107622

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12107622%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

exact match

https://scigraph.springernature.com/pub.10.1007/s00213-002-1060-z

0 references

(Q74433078)

Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)